XML 15 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ (11,315)   $ 1 $ 451 $ 156 $ (11,923)
Beginning Balance, Shares at Dec. 31, 2020   22,012,499        
Beginning Balance at Dec. 31, 2020   $ 45,356        
Beginning Balance, Shares at Dec. 31, 2020     15,957,821      
Issuance of Series A and Series B convertible preferred stock, net of issuance costs   $ 124,712        
Issuance of Series A and Series B convertible preferred stock, net of issuance costs, Shares   19,083,979        
Preferred stock converted into shares of common stock 170,068   $ 4 170,064    
Preferred stock converted into shares of common stock, Shares   (41,096,478)        
Preferred stock converted into shares of common stock   $ (170,068)        
Preferred stock converted into shares of common stock, Shares     25,212,548      
Initial public offering of common shares, net of $21,728 of issuance costs 254,271   $ 1 254,270    
Initial public offering of common shares, net of $21,728 of issuance costs, Shares     13,800,000      
Exercises of stock options and vesting of restricted stock 3     3    
Exercises of stock options and vesting of restricted stock, Shares     72,181      
Stock-based compensation 647     647    
Unrealized loss on investments (154)       (154)  
Net loss (5,514)         (5,514)
Ending Balance at Mar. 31, 2021 408,006   $ 6 425,435 2 (17,437)
Ending Balance, Shares at Mar. 31, 2021     55,042,550      
Beginning Balance at Dec. 31, 2021 382,130   $ 6 429,824 (244) (47,456)
Beginning Balance, Shares at Dec. 31, 2021     55,441,926      
Exercises of stock options and vesting of restricted stock 162     162    
Exercises of stock options and vesting of restricted stock, Shares     176,400      
Stock-based compensation 2,360     2,360    
Unrealized loss on investments (1,078)       (1,078)  
Net loss (13,265)         (13,265)
Ending Balance at Mar. 31, 2022 $ 370,309   $ 6 $ 432,346 $ (1,322) $ (60,721)
Ending Balance, Shares at Mar. 31, 2022     55,618,326